Health

Ema, CHMP green light for the Moderna vaccine in the 6-11 age group

ADVERTISING
Rome, 25 February – The CHMP, the EMA Committee for Medicinal Products for Human Use, has recommended that Spikevax, the Moderna Sars CoV 2 vaccine, an extension of the indication, which also includes the age group of 6 to 11 years. The vaccine has already been approved for administration over the age of 12 seconds.

ADVERTISING

ADVERTISING
1 of 6